The University of Chicago Header Logo

Connection

Andrea C. King to Middle Aged

This is a "connection" page, showing publications Andrea C. King has written about Middle Aged.
Connection Strength

0.515
  1. Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial. Alcohol Alcohol. 2019 Jan 09; 54(5):559-565.
    View in: PubMed
    Score: 0.042
  2. Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African Americans: an analysis of a randomized controlled trial. Pharmacogenet Genomics. 2015 Jun; 25(6):305-12.
    View in: PubMed
    Score: 0.033
  3. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking. Alcohol Clin Exp Res. 2014 Oct; 38(10):2622-9.
    View in: PubMed
    Score: 0.032
  4. Feasibility and effectiveness of a community-based smoking cessation intervention in a racially diverse, urban smoker cohort. Am J Public Health. 2014 Sep; 104 Suppl 4:S620-7.
    View in: PubMed
    Score: 0.031
  5. Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial. Addiction. 2013 Oct; 108(10):1836-44.
    View in: PubMed
    Score: 0.029
  6. Modifiable risk behaviors in patients with head and neck cancer. Cancer. 2013 Jul 01; 119(13):2419-26.
    View in: PubMed
    Score: 0.028
  7. Project Exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care STDS. 2013 Jan; 27(1):22-32.
    View in: PubMed
    Score: 0.028
  8. Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial. Biol Psychiatry. 2013 May 01; 73(9):924-30.
    View in: PubMed
    Score: 0.028
  9. Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. J Clin Psychopharmacol. 2012 Oct; 32(5):630-6.
    View in: PubMed
    Score: 0.027
  10. Racial differences in eligibility and enrollment in a smoking cessation clinical trial. Health Psychol. 2011 Jan; 30(1):40-8.
    View in: PubMed
    Score: 0.024
  11. Acute HPA axis response to naltrexone differs in female vs. male smokers. Psychoneuroendocrinology. 2010 May; 35(4):596-606.
    View in: PubMed
    Score: 0.022
  12. A pilot community-based intensive smoking cessation intervention in African Americans: feasibility, acceptability and early outcome indicators. J Natl Med Assoc. 2008 Feb; 100(2):208-17.
    View in: PubMed
    Score: 0.020
  13. Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences. Nicotine Tob Res. 2006 Oct; 8(5):671-82.
    View in: PubMed
    Score: 0.018
  14. Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. J Subst Abuse Treat. 2004 Apr; 26(3):189-95.
    View in: PubMed
    Score: 0.015
  15. Naltrexone attenuates acute cigarette smoking behavior. Pharmacol Biochem Behav. 2004 Jan; 77(1):29-37.
    View in: PubMed
    Score: 0.015
  16. Alcohol-induced performance impairment in heavy episodic and light social drinkers. J Stud Alcohol. 2004 Jan; 65(1):27-36.
    View in: PubMed
    Score: 0.015
  17. Stressful events, personality, and mood disturbance: gender differences in alcoholics and problem drinkers. Addict Behav. 2003 Jan-Feb; 28(1):171-87.
    View in: PubMed
    Score: 0.014
  18. Role of naltrexone in initial smoking cessation: preliminary findings. Alcohol Clin Exp Res. 2002 Dec; 26(12):1942-4.
    View in: PubMed
    Score: 0.014
  19. Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism. Neuropsychopharmacology. 2002 Jun; 26(6):778-88.
    View in: PubMed
    Score: 0.013
  20. Naltrexone alteration of acute smoking response in nicotine-dependent subjects. Pharmacol Biochem Behav. 2000 Jul; 66(3):563-72.
    View in: PubMed
    Score: 0.012
  21. Differential fMRI BOLD responses in amygdala in intermittent explosive disorder as a function of past Alcohol Use Disorder. Psychiatry Res Neuroimaging. 2016 Nov 30; 257:5-10.
    View in: PubMed
    Score: 0.009
  22. Substance use disorders: Relationship with intermittent explosive disorder and with aggression, anger, and impulsivity. J Psychiatr Res. 2016 10; 81:127-32.
    View in: PubMed
    Score: 0.009
  23. The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology (Berl). 2013 May; 227(1):177-92.
    View in: PubMed
    Score: 0.007
  24. Race and sex associations to weight concerns among urban African American and Caucasian smokers. Addict Behav. 2011 Jan-Feb; 36(1-2):14-7.
    View in: PubMed
    Score: 0.006
  25. Effect of clinician advice and patient preparedness to quit on subsequent quit attempts in hospitalized smokers. J Hosp Med. 2010 Jan; 5(1):26-32.
    View in: PubMed
    Score: 0.006
  26. Development of a culturally targeted smoking cessation intervention for African American smokers. J Community Health. 2009 Dec; 34(6):480-92.
    View in: PubMed
    Score: 0.006
  27. Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts. Inflamm Bowel Dis. 2007 May; 13(5):573-9.
    View in: PubMed
    Score: 0.005
  28. Cardiovascular responses to physical and psychological stress in female alcoholics with transitory hypertension after early abstinence. Alcohol Clin Exp Res. 2003 Sep; 27(9):1489-98.
    View in: PubMed
    Score: 0.004
  29. Cortisol dysregulation and cognitive impairment in abstinent male alcoholics. Alcohol Clin Exp Res. 2002 Aug; 26(8):1198-204.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.